ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
FEMS Microbiology Letters
Volume 249, Issue 1, 1 August 2005, Pages 185-190
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.femsle.2005.06.038    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Federation of European Microbiological Societies Published by Elsevier B.V.

Staphylococcal Drp35 is the functional counterpart of the eukaryotic PONs

Kazuya Morikawa1, E-mail The Corresponding Author, Toshie Hidaka1, Hiroyuki Murakami, Hideo Hayashi2 and Toshiko OhtaCorresponding Author Contact Information, E-mail The Corresponding Author

Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennoh-dai, Tsukuba 305-8575, Japan

Received 2 April 2005; 
revised 7 June 2005; 
accepted 9 June 2005. 
Available online 5 July 2005.

This article is not included in your organization's subscription. However, you may be able to access this article under your organization's agreement with Elsevier.

Abstract

Drp35 has been identified as a protein that is induced in Staphylococcus aureus in response to exposure to certain antibiotics. Here we demonstrate that Drp35 is a lactonase that does not contribute directly to the resistance to the inducer antibiotics except for bacitracin. The detailed analysis on the expression of Drp35 revealed that in addition to a broad range of antibiotics, agents such as detergents that perturb the membrane integrity could induce its expression. The significance of this characteristic expression is discussed in relation to its activity similarity to the eukaryotic counterparts, paraoxonase family proteins.

Keywords: Staphylococcus aureus; Drp35; Paraoxionase; Membrane integrity

Article Outline

1. Introduction
2. Materials and methods
2.1. Bacterial strains
2.2. Construction of drp35 disruptant, NM6
2.3. Construction of drp35 overexpressing strain, NMDR
2.4. Western blot analysis
2.5. Antibiotic susceptibility tests
2.6. Preparation of the recombinant Drp35 protein
2.7. Enzyme assay
3. Results
3.1. Is Drp35 required for the antibiotic resistance?
3.2. Drp35 is functional protein with calcium-dependent lactonase activity
3.3. Expression profile of Drp35
4. Discussion
4.1. Drp35 contributes to the bacitracin resistance
4.2. Drp35 acts in cells with perturbed membrane integrity
4.3. Drp35 is the bacterial counterpart of eukaryotic paraoxonase family proteins
Acknowledgements
References




FEMS Microbiology Letters
Volume 249, Issue 1, 1 August 2005, Pages 185-190
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.